Literature DB >> 19096215

Characterization of 11p14-p12 deletion in WAGR syndrome by array CGH for identifying genes contributing to mental retardation and autism.

S Xu1, J C Han, A Morales, C M Menzie, K Williams, Y-S Fan.   

Abstract

WAGR (Wilms tumor, Aniridia, Genitourinary malformations and mental Retardation) syndrome is a rare genomic disorder caused by deletion of the 11p14-p12 chromosome region. The majority of WAGR patients have mental retardation and behavioral problems, and more than 20% of the patients also have features of autism. While the Wilms tumor/genitourinary anomalies and aniridia are caused by deletion of WT1 and PAX6 respectively, the genomic cause of mental retardation and autism in WAGR syndrome remains unknown. Using oligonucleotide arrays, we have characterized the 11p14-p12 deletions in 31 patients and identified all the genes involved in each deletion. The deletions had sizes ranging from 4.9 to 23 Mb that encompass 18-62 genes (40 on average). In addition to WT1 and PAX6, all the patients had deletion of PRRG4 (transmembrane gamma-carboxyglutamic acid protein 4). The majority of them had deletion of BDNF (brain-derived neurotrophic factor) and SLC1A2 [solute carrier family 1 (glial high affinity glutamate transporter) member 2]. Deletion of BDNF and SLC1A2 occurred in patients with autism more frequently than in those without autism. Literature review on the functions of the genes suggests that haploinsufficiency of SLC1A2, PRRG4, and BDNF may contribute to mental retardation and behavioral problems. In particular, BDNF may modulate the risk of autism in WAGR patients as suggested by its link with Rett syndrome as a target of MECP2. We observed that all the de novo deletions occurred in the chromosome 11 inherited from the father in the families genotyped, implying a predisposition for de novo mutations occurring in spermatogenesis and possible involvement of imprinting in cognitive impairment in WAGR patients. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 19096215     DOI: 10.1159/000172086

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  33 in total

1.  Recurrent SLC1A2 variants cause epilepsy via a dominant negative mechanism.

Authors:  Andrew B Stergachis; Jonai Pujol-Giménez; Gergely Gyimesi; Daniel Fuster; Giusppe Albano; Marina Troxler; Jonathan Picker; Paul A Rosenberg; Ann Bergin; Jurriaan Peters; Christelle Moufawad El Achkar; Chellamani Harini; Shannon Manzi; Alexander Rotenberg; Matthias A Hediger; Lance H Rodan
Journal:  Ann Neurol       Date:  2019-04-26       Impact factor: 10.422

2.  Chromosomal Microarray Analysis in Children with Unexplained Developmental Delay/Intellectual Disability.

Authors:  Pinar Arican; Nihal Olgac Dundar; Berk Ozyilmaz; Dilek Cavusoglu; Pinar Gencpinar; Kadri Murat Erdogan; Merve Saka Guvenc
Journal:  J Pediatr Genet       Date:  2018-12-14

Review 3.  Aniridia.

Authors:  Melanie Hingorani; Isabel Hanson; Veronica van Heyningen
Journal:  Eur J Hum Genet       Date:  2012-06-13       Impact factor: 4.246

4.  Astroglia and Obsessive Compulsive Disorder.

Authors:  Kohichi Tanaka
Journal:  Adv Neurobiol       Date:  2021

5.  Results From the WAGR Syndrome Patient Registry: Characterization of WAGR Spectrum and Recommendations for Care Management.

Authors:  Kelly A Duffy; Kelly L Trout; Jennifer M Gunckle; Shari McCullen Krantz; John Morris; Jennifer M Kalish
Journal:  Front Pediatr       Date:  2021-12-14       Impact factor: 3.418

6.  A de novo 11p13 Microduplication in a Patient with Some Features Invoking Silver-Russell Syndrome.

Authors:  O Palumbo; T Mattina; P Palumbo; M Carella; C S Perrotta
Journal:  Mol Syndromol       Date:  2013-11-28

7.  Neurobiology, Functions, and Relevance of Excitatory Amino Acid Transporters (EAATs) to Treatment of Refractory Epilepsy.

Authors:  Aleksey V Zaitsev; Ilya V Smolensky; Pascal Jorratt; Saak V Ovsepian
Journal:  CNS Drugs       Date:  2020-11       Impact factor: 5.749

8.  LGR4/GPR48 inactivation leads to aniridia-genitourinary anomalies-mental retardation syndrome defects.

Authors:  Tingfang Yi; Jinsheng Weng; Stefan Siwko; Jian Luo; Dali Li; Mingyao Liu
Journal:  J Biol Chem       Date:  2014-02-11       Impact factor: 5.157

9.  Assessment of PAX6 alleles in 66 families with aniridia.

Authors:  A M Bobilev; M E McDougal; W L Taylor; E E Geisert; P A Netland; J D Lauderdale
Journal:  Clin Genet       Date:  2016-01-25       Impact factor: 4.438

10.  Association of brain-derived neurotrophic factor (BDNF) haploinsufficiency with lower adaptive behaviour and reduced cognitive functioning in WAGR/11p13 deletion syndrome.

Authors:  Joan C Han; Audrey Thurm; Christine Golden Williams; Lisa A Joseph; Wadih M Zein; Brian P Brooks; John A Butman; Sheila M Brady; Shannon R Fuhr; Melanie D Hicks; Amanda E Huey; Alyson E Hanish; Kristen M Danley; Margarita J Raygada; Owen M Rennert; Keri Martinowich; Stephen J Sharp; Jack W Tsao; Susan E Swedo
Journal:  Cortex       Date:  2013-02-19       Impact factor: 4.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.